Key facts
- This page summarizes Pamela Bush's Form 3 filing for Predictive Oncology Inc. (POAI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Feb 2023, 14:37.
Pamela Bush - 31 Jan 2023 Form 3 Insider Report for Predictive Oncology Inc. (POAI)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- POAI
- Reported as of
- 31 Jan 2023
- Net transaction value
- $0
- Reporting owner signature
- /s/ Bob Myers, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Pamela Bush filed Form 3 for Predictive Oncology Inc. (POAI) on 10 Feb 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
POAI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 47,373
- Date
- 31 Jan 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24.1 Power of Attorney filed herewith.